F

Fenway Health | The Fenway Institute

Research site

(Unclaimed)

Location

1340 Boylston Street, Boston, Massachusetts, United States of America

Site insights

Top conditions

Top treatments

Emtricitabine

Atazanavir

Truvada

Ritonavir

imiquimod

fluorouracil

PrEP

Lenacapavir

MK-8527-007

MK-8527

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 35 total trials

A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes

The purpose of this study is to generate safety and immunogenicity data and establish a proof-of-concept of clinical benefit of the mRNA-1608 vaccine...

Active, not recruiting

Genital Herpes

Biological: mRNA-1608

Biological: BEXSERO

Safety and Pharmacokinetic Study of Oral MK-8527 QM in Participants at Low-Risk for HIV-1 Infection (MK-8527-007)

This double-blind, placebo-controlled study is designed to assess the safety, tolerability, and pharmacokinetics of oral MK-8527 taken once monthly (...

Active, not recruiting

HIV

HIV Pre-exposure Prophylaxis

Drug: MK-8527

Drug: Placebo to MK-8527

SmartSteps: A Context-Aware, PrEP Adherence Intervention for Individuals With Substance Use Disorder

This is a single-arm, observational study of HIV-negative MSM with substance use disorder. Those who meet pre-screening criteria will attend a Screen...

Enrolling

Substance Use

Adherence, Treatment

Drug: Descovy or Truvada

Device: Beiwe

Study of Lenacapavir for HIV Pre-Exposure Prophylaxis in People Who Are at Risk for HIV Infection (PURPOSE 2)

The goal of this clinical study is to test how well the study drug, lenacapavir (LEN), works in preventing the risk of HIV.

Active, not recruiting

Pre-Exposure Prophylaxis of HIV Infection

Drug: PTM F/TDF

Drug: Placebo SC LEN

Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesions (ANCHOR)

The randomized phase of the trial compared topical or ablative treatment with active monitoring in preventing anal cancer in patients with human immu...

Active, not recruiting

Anal Cancer

High-grade Squamous Intraepithelial Lesion

Device: laser therapy

Other: clinical observation